SCHEMBL5859710

SCHEMBL5859710

CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4cc(C#N)ccc43)c3ccc4c(c3)OOC4)cc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.39
PDGFRB P09619 2/20 0.36
FGFR1 P11362 2/20 0.36
PDGFRA P16234 2/20 0.36
FLT1 P17948 2/20 0.36
FGFR2 P21802 2/20 0.36
FGFR4 P22455 2/20 0.36
FGFR3 P22607 2/20 0.36
FLT4 P35916 2/20 0.36
KDR P35968 2/20 0.36
ABL1 P00519 1/20 0.36
NTRK1 P04629 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
KIT P10721 1/20 0.36
NTRK3 Q16288 1/20 0.36
NAMPT P43490 5/20 0.36
MELK Q14680 6/20 0.33
CHEK1 O14757 2/20 0.33
PRKAB2 O43741 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5856778 0.93 AAK1 (0.39) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3935847 0.90 AAK1 (0.41) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3935527 0.90 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3936697 0.90 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3935444 0.89 AAK1 (0.39) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3935449 0.89 AAK1 (0.39) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3933352 0.89 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3933357 0.89 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3933455 0.89 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1
SCHEMBL3933461 0.89 AAK1 (0.40) AAK1PDGFRBFGFR1PDGFRAFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7148249-B2 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-12-12 US disclosed
US-20050054710-A1 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054710-A1 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments CDK1, CDK2, CDK3 AAK1 1459/4885PDGFRB 609/4885FGFR1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.